Taro Pharmaceutical Industries Performance
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Taro Pharmaceutical are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Taro Pharmaceutical Industries has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Taro Pharmaceutical is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 154.5 M |
Taro |
Taro Pharmaceutical Relative Risk vs. Return Landscape
If you would invest (100.00) in Taro Pharmaceutical Industries on December 28, 2024 and sell it today you would earn a total of 100.00 from holding Taro Pharmaceutical Industries or generate -100.0% return on investment over 90 days. Taro Pharmaceutical Industries is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Taro, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Taro Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Taro Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Taro Pharmaceutical Industries, and traders can use it to determine the average amount a Taro Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TARO |
Based on monthly moving average Taro Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Taro Pharmaceutical by adding Taro Pharmaceutical to a well-diversified portfolio.
Taro Pharmaceutical Fundamentals Growth
Taro Stock prices reflect investors' perceptions of the future prospects and financial health of Taro Pharmaceutical, and Taro Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Taro Stock performance.
| Return On Equity | 0.0306 | |||
| Return On Asset | 0.0021 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 735.67 M | |||
| Shares Outstanding | 37.58 M | |||
| Price To Earning | 14.57 X | |||
| Price To Book | 0.89 X | |||
| Price To Sales | 2.59 X | |||
| Revenue | 629.18 M | |||
| EBITDA | 52.6 M | |||
| Cash And Equivalents | 806.25 M | |||
| Cash Per Share | 21.45 X | |||
| Total Debt | 369.06 M | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 47.70 X | |||
| Cash Flow From Operations | 132.39 M | |||
| Earnings Per Share | 1.43 X | |||
| Total Asset | 2.16 B | |||
| Retained Earnings | 2.41 B | |||
| Current Asset | 1.88 B | |||
| Current Liabilities | 245.46 M | |||
Things to note about Taro Pharmaceutical performance evaluation
Checking the ongoing alerts about Taro Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Taro Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Taro Pharmaceutical is not yet fully synchronised with the market data | |
| Taro Pharmaceutical has some characteristics of a very speculative penny stock | |
| Taro Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
| About 78.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Taro Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Taro Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Taro Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Taro Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Taro Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Taro Pharmaceutical's stock. These opinions can provide insight into Taro Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Taro Stock
If you are still planning to invest in Taro Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taro Pharmaceutical's history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |